Being keen on the up-down activities of the market here are the predictions one can clearly presume for the Share Market.
S&P assumes India's GDP to contract 9% in FY21 India's GDP will experience a record contraction in FY21 due to the Covid pandemic with some abiding damage, while damaging revenue positions will constrain the government’s ability to support the economy, S&P Global Ratings said on Friday.
As Covid-19 patience, a recovery emerged faster than previous recoveries in a country like India which is filled by such a vast population is remarkable.
In the US, the conditions are worsening because cases are increasing day by day. There are chances to have new lockdowns that will impact the economy of America.
Pfizer pharma gave its hellfire outputs these months which was glorious in the market field.
Gland Pharma listing this week on November 20, pharmaceuticals biggest offering lastly subscribed 2.06 times final day. The IPO fetched Rs.6,480 cr, at the upper end of the price band Rs.1,490-1,500 per share.
Dollar index down to 92.5. FII flows set to sustain, it starts to break 92 that would mean a fresh bear market for the dollar. FII flows in Nov at $405 bn, some more MSCI flows likely.
